Results announced from EMPACT-MI phase III trial investigating the effect of Jardiance® on risk of heart failure hospitalization and death in adults following a.
Boehringer Ingelheim and Carelon Research have conducted the first large-scale U.S. validation of a new AI-driven tool for chronic kidney disease (CKD) The Klinrisk model predicted disease progression in over 80% of individuals at all stages of the disease, based on data from a diverse population of over 4 million U.S. adults Validated tools to […]
/PRNewswire/ Boehringer Ingelheim and Carelon Research have conducted a validation study of the Klinrisk model, a machine-learning tool developed to predict.
Novel AI-Driven Model Validated to Predict Risk of Chronic Kidney Disease Progression in Large U S Study streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.